Anzeige
Mehr »
Login
Samstag, 22.01.2022 Börsentäglich über 12.000 News von 667 internationalen Medien
Entscheidende Wochen stehen an! Kommt jetzt ein lukratives Übernahme-Angebot?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSR6 ISIN: CA00430K8730 Ticker-Symbol: A1P 
Tradegate
20.01.22
16:40 Uhr
1,230 Euro
+0,180
+17,14 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ACASTI PHARMA INC Chart 1 Jahr
5-Tage-Chart
ACASTI PHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0601,08012:37
1,0201,08021.01.

Aktuelle News zur ACASTI Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.01.Acasti Pharma, Inc.: Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference3
ACASTI Aktie jetzt für 0€ handeln
22.12.21ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $69
22.12.21See Why Acasti Pharma Shares Are Trading Over 20% Higher?7
22.12.21Pre-market Movers: BioRestorative Therapies, Red Cat Holdings, American Virtual Cloud Technologies, Acasti Pharma, DBV Technologies316MARTINSRIED (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.10 A.M. ET).In the GreenBioRestorative Therapies, Inc. (BRTX) is up...
► Artikel lesen
22.12.21Acasti Pharma jumps 21% on new Outperform rating at Oppenheimer with PT of $67
02.12.21Acasti Pharma Inc (3): Acasti Pharma releases GTX-104 bridging study results2
02.12.21Acasti Pharma's Hemorrhage Candidate Shows Encouraging PK Profile In Healthy Volunteers1
02.12.21Acasti says candidate for subarachnoid hemorrhage met main goals in pivotal PK study-
02.12.21Acasti Pharma Inc. - 8-K, Current Report1
02.12.21Acasti Pharma, Inc.: Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-1042
24.11.21Acasti Pharma, Inc.: Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd-
12.11.21Acasti Pharma Inc (3): Acasti grants options to buy 2,07 million shares5
12.11.21Acasti Pharma, Inc.: Acasti Pharma Announces Annual Stock Option Grants3
11.11.21The Investor Summit: Acasti Pharma To Present At The Q4 Investor Summit on November 16th171Laval, Quebec--(Newsfile Corp. - November 11, 2021) - Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) ("Acasti" or the "Company"), today announced that management will present at the Q4 Investor Summit...
► Artikel lesen
10.11.21Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earning Call Transcript1
10.11.21Acasti Pharma Inc (3): Acasti spends $550,000 (U.S.) on R&D in Q2 2021-
10.11.21Acasti Pharma Inc. - 8-K, Current Report-
10.11.21Acasti Pharma Inc. - 10-Q, Quaterly Report-
09.11.21Acasti Pharma Q2 Earnings Preview-
04.11.21Acasti Pharma Inc (3): Acasti Pharma to hold Q2 conference call Nov. 101
Seite:  Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,2,1